Validea Detailed Fundamental Analysis - TGTX
Nasdaq Below is Validea's guru fundamental report for TG THERAPEUTICS INC (TGTX). Of the 22 guru strategies we follow, TGTX rates highest using our Quantitative Momentum Investor model based on the published strategy of Wesley Gray. This momentum model looks for stocks with strong and consistent intermediate-term relative performance.
TG THERAPEUTICS INC (TGTX) is a mid-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 66% based on the firms underlying fundamentals and the stocks valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
